Rejection, Transplant Completed Phase 4 Trials for Rituximab (DB00073)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00476164Study of Rituximab to Treat Chronic Renal Transplant RejectionTreatment